RecruitingNCT04736667
Mitral Valve Screening Survey
Mitral Valve Screening Survey (MVSS)
Sponsor
Medstar Health Research Institute
Enrollment
1,000 participants
Start Date
Aug 6, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study aims to examine the clinical profile/anatomical characteristics and natural history of patients who subsequently fail screening for transcatheter mitral valve intervention (TMVI).
Eligibility
Min Age: 18 Years
Inclusion Criteria1
- Subject failed screening for TMVI
Exclusion Criteria3
- Under 18 years of age
- Subject unable or unwilling to give informed consent
- Subject proceeded with TMVI.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(16)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04736667
Related Trials
Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery
NCT029258193 locations
MitrAl Valve Calcium aSsEssmEnt With TrueVue Trans-illumination 3D Rendering.
NCT076125531 location
Abbott Cephea Mitral Valve Disease Registry
NCT0706967322 locations
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT0468819043 locations
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
NCT0440843017 locations